{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:33:23Z","timestamp":1772195603796,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Startup Fund for Scientific Research, Fujian Medical University","award":["2019QH1146"],"award-info":[{"award-number":["2019QH1146"]}]},{"name":"The Natural Science Foundation of Fujian Provinc","award":["2020J011063"],"award-info":[{"award-number":["2020J011063"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian province","award":["2024Y9028"],"award-info":[{"award-number":["2024Y9028"]}]},{"name":"Guided Project of Social Development in Fujian Province","award":["2025Y0006"],"award-info":[{"award-number":["2025Y0006"]}]},{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program Project","award":["2025ZL118"],"award-info":[{"award-number":["2025ZL118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11596-026-00167-y","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:33:43Z","timestamp":1770647623000},"page":"173-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitofusin 2 Alleviates Liver Fibrogenesis by Suppressing \u03b2-Catenin Nuclear Translocation"],"prefix":"10.1007","volume":"46","author":[{"given":"Chai-ming","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-ling","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-jie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-4697","authenticated-orcid":false,"given":"Gui-sheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"4","key":"167_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u2013238.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"4","key":"167_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14656566.2014.876992","volume":"15","author":"A Sahebkar","year":"2014","unstructured":"Sahebkar A, Chew GT, Watts GF. New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert Opin Pharmacother. 2014;15(4):493\u2013503.","journal-title":"Expert Opin Pharmacother."},{"issue":"17","key":"167_CR3","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, et al. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281(17):12093\u201312101.","journal-title":"J Biol Chem."},{"issue":"3","key":"167_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/jcp.22833","volume":"227","author":"TF Kuo","year":"2012","unstructured":"Kuo TF, Tatsukawa H, Matsuura T, et al. Free fatty acids induce transglutaminase 2-dependent apoptosis in hepatocytes via ER stress-stimulated PERK pathways. J Cell Physiol. 2012;227(3):1130\u20131137.","journal-title":"J Cell Physiol."},{"issue":"4","key":"167_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.27678","volume":"61","author":"AJ Sanyal","year":"2015","unstructured":"Sanyal AJ, Friedman SL, McCullough AJ, et al. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology. 2015;61(4):1392\u20131405.","journal-title":"Hepatology."},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.lfs.2017.03.012","volume":"176","author":"NN Duan","year":"2017","unstructured":"Duan NN, Liu XJ, Wu J. Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. Life Sci. 2017;176:42\u201353.","journal-title":"Life Sci."},{"issue":"2","key":"167_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s40200-022-01095-z","volume":"21","author":"G Mohammadzadeh","year":"2022","unstructured":"Mohammadzadeh G, Afarin R, Bavarsad SS, et al. Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis. J Diabetes Metab Disord. 2022;21(2):1531\u20131538.","journal-title":"J Diabetes Metab Disord."},{"issue":"2","key":"167_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/brv.12378","volume":"93","author":"G Chandhok","year":"2018","unstructured":"Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93(2):933\u2013949.","journal-title":"Biol Rev Camb Philos Soc."},{"issue":"4","key":"167_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","volume":"177","author":"MI Hern\u00e1ndez-Alvarez","year":"2019","unstructured":"Hern\u00e1ndez-Alvarez MI, Sebasti\u00e1n D, Vives S, et al. Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease. Cell. 2019;177(4):881\u2013895.e17.","journal-title":"Cell."},{"issue":"5","key":"167_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/19768354.2018.1512523","volume":"22","author":"K Jung","year":"2018","unstructured":"Jung K. Betaine enhances the cellular survival via mitochondrial fusion and fission factors, MFN2 and DRP1. Anim Cells Syst. 2018;22(5):289\u2013298.","journal-title":"Anim Cells Syst."},{"issue":"1","key":"167_CR11","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/s41467-021-23047-6","volume":"12","author":"YM Kim","year":"2021","unstructured":"Kim YM, Krantz S, Jambusaria A, et al. Mitofusin-2 stabilizes adherens junctions and suppresses endothelial inflammation via modulation of \u03b2-catenin signaling. Nat Commun. 2021;12(1):2736.","journal-title":"Nat Commun."},{"issue":"1","key":"167_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13287-022-02836-w","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng L, Yi S, Yin X, et al. MFN2 knockdown promotes osteogenic differentiation of iPSC-MSCs through aerobic glycolysis mediated by the Wnt\/\u03b2-catenin signaling pathway. Stem Cell Res Ther. 2022;13(1):162.","journal-title":"Stem Cell Res Ther."},{"issue":"11","key":"167_CR13","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1111\/bph.15289","volume":"178","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang F, He J, et al. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt\/\u03b2-catenin signalling via interaction with Gli1. Br J Pharmacol. 2021;178(11):2246\u20132265.","journal-title":"Br J Pharmacol."},{"issue":"4","key":"167_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/abbs\/gmt143","volume":"46","author":"W Chang","year":"2014","unstructured":"Chang W, Yang M, Song L, et al. Isolation and culture of hepatic stellate cells from mouse liver. Acta Biochim Biophys Sin. 2014;46(4):291\u2013298.","journal-title":"Acta Biochim Biophys Sin."},{"issue":"2","key":"167_CR15","doi-asserted-by":"publisher","first-page":"e0048421","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, et al. The protective effects of live and pasteurized akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr. 2021;9(2):e0048421.","journal-title":"Microbiol Spectr."},{"issue":"2","key":"167_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289\u2013293.","journal-title":"Hepatology."},{"key":"167_CR17","first-page":"6731335","volume":"2022","author":"Z Chen","year":"2022","unstructured":"Chen Z, Lin Z, Yu J, et al. Mitofusin-2 restrains hepatic stellate cells\u2019 proliferation via PI3K\/Akt signaling pathway and inhibits liver fibrosis in rats. J Healthc Eng. 2022;2022:6731335.","journal-title":"J Healthc Eng."},{"issue":"4","key":"167_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11596-024-2879-x","volume":"44","author":"CM Zeng","year":"2024","unstructured":"Zeng CM, Shao B, Chen YP, et al. Silencing MFN2 drives WNT\/\u03b2-catenin nucleation to reduce sorafenib sensitivity in hepatocellular carcinoma cells. Curr Med Sci. 2024;44(4):789\u2013798.","journal-title":"Curr Med Sci."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00167-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:03:32Z","timestamp":1772190212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00167-y","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no financial interests\/personal relationships which may be considered as potential competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All animal procedures were conducted in strict accordance with institutional guidelines for the care and use of laboratory animals. The experimental protocol was approved by the Animal Welfare and Ethics Committee of Fujian Provincial Hospital (Approval No. IACUC-FPH-SL-20241218[0466]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\u00a0and Consent to Participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}